Cytomos Secures £5m to Enhance Cell-Analysis Technology
Deal News | Nov 21, 2024 | Scottish Enterprise
Cytomos, a biotechnology company based in Edinburgh, has successfully raised £5 million to expand the production capabilities of its pioneering cell-analysis technology. This funding round was led by Scottish Enterprise, demonstrating solid investor confidence and interest in Cytomos's innovative solutions. The company aims to use the funds to accelerate the commercialization process of its cell-analysis technology, which is designed to improve the efficiency and accuracy of biological research. This monetary injection will also support Cytomos's efforts to expand its workforce and enhance its operational infrastructure.
Sectors
- Biotechnology
- Private Equity
Geography
- United Kingdom – Cytomos is based in Edinburgh, Scotland, making the United Kingdom a relevant location for the company's operations and growth.
Industry
- Biotechnology – The sector focuses on technological innovations related to biological research, which is central to Cytomos's unique cell-analysis technology.
- Private Equity – Involves investments in private companies by firms like Scottish Enterprise, which is backing Cytomos in scaling its technology.
Financials
- £5 million – The amount raised by Cytomos to scale up production of its cell-analysis technology.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Cytomos | Target Company | Company | An Edinburgh-based biotechnology company specializing in cell-analysis technology. |
| Scottish Enterprise | Private Equity Firm | Company | A Scottish investment organization that supports the growth of companies in Scotland through funding and resources. |